These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28901860)

  • 21. Introduction to the Special Issue: Using neuroimaging to probe mechanisms of behavior change.
    Chung T; Tittgemeyer M; Feldstein Ewing SW
    Neuroimage; 2017 May; 151():1-3. PubMed ID: 28108393
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroimaging in psychiatry: Steps toward the clinical application of brain imaging in psychiatric disorders.
    Won E; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):69-70. PubMed ID: 28962844
    [No Abstract]   [Full Text] [Related]  

  • 23. Recognition and Appropriate Use of Magnetic Resonance Imaging for Emergent Neuroradiology.
    Rozell JM; Li S
    Semin Ultrasound CT MR; 2017 Aug; 38(4):424-438. PubMed ID: 28865531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten years of enhancing neuro-imaging genetics through meta-analysis: An overview from the ENIGMA Genetics Working Group.
    Medland SE; Grasby KL; Jahanshad N; Painter JN; Colodro-Conde L; Bralten J; Hibar DP; Lind PA; Pizzagalli F; Thomopoulos SI; Stein JL; Franke B; Martin NG; Thompson PM;
    Hum Brain Mapp; 2022 Jan; 43(1):292-299. PubMed ID: 33300665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrinologic features of skull and hand roentgenograms in psychiatric patients.
    Kraft E; Finby N
    Clin Radiol; 1967 Jul; 18(3):272-5. PubMed ID: 6029379
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical Applications of Neuroimaging in Psychiatric Disorders.
    First MB; Drevets WC; Carter C; Dickstein DP; Kasoff L; Kim KL; McConathy J; Rauch S; Saad ZS; Savitz J; Seymour KE; Sheline YI; Zubieta JK
    Am J Psychiatry; 2018 Sep; 175(9):915-916. PubMed ID: 30173550
    [No Abstract]   [Full Text] [Related]  

  • 27. Nuclear medicine in psychiatry.
    Lass P; Sławek J
    Nucl Med Rev Cent East Eur; 2007; 10(2):116-24. PubMed ID: 18228217
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroimaging Abnormalities in Neurological Patients with Criminal Behavior.
    Darby RR
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):47. PubMed ID: 29904892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders.
    Bhattacharya A; Ceusters M
    Neuropsychopharmacology; 2020 Jan; 45(1):234-235. PubMed ID: 31477815
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroimaging Advances in Neurologic and Neurodegenerative Diseases.
    Risacher SL; Saykin AJ
    Neurotherapeutics; 2021 Apr; 18(2):659-660. PubMed ID: 34410634
    [No Abstract]   [Full Text] [Related]  

  • 31. Addressing reverse inference in psychiatric neuroimaging: Meta-analyses of task-related brain activation in common mental disorders.
    Sprooten E; Rasgon A; Goodman M; Carlin A; Leibu E; Lee WH; Frangou S
    Hum Brain Mapp; 2017 Apr; 38(4):1846-1864. PubMed ID: 28067006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging-Based Subtyping for Psychiatric Syndromes.
    Ivleva EI; Turkozer HB; Sweeney JA
    Neuroimaging Clin N Am; 2020 Feb; 30(1):35-44. PubMed ID: 31759570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders.
    Slifstein M; Abi-Dargham A
    Semin Nucl Med; 2017 Jan; 47(1):54-63. PubMed ID: 27987558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Of fractal and Fourier: A measure for local shape complexity for neurological applications.
    Walsh EI; Zhang T; Cherbuin N
    J Neurosci Methods; 2019 Jul; 323():61-67. PubMed ID: 31125590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transependymal Movement of Cerebrospinal Fluid in Neurological and Psychiatric Pathological Conditions.
    Alexander S
    Acta Neurochir Suppl; 2016; 122():295-300. PubMed ID: 27165925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic neuroimaging across diseases.
    Klöppel S; Abdulkadir A; Jack CR; Koutsouleris N; Mourão-Miranda J; Vemuri P
    Neuroimage; 2012 Jun; 61(2):457-63. PubMed ID: 22094642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of multimodal neuroimaging markers for neurological disorders - Part 2.
    Wong KK; Wang D; Liang P
    J Xray Sci Technol; 2016 Mar; 24(3):439-41. PubMed ID: 27002913
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
    Hesse S; Barthel H; Schwarz J; Sabri O; Müller U
    Neurosci Biobehav Rev; 2004 Oct; 28(6):547-63. PubMed ID: 15527862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An automatic 3D brain segmentation based on improved level-set method in micro-CT rat/mouse images].
    Chen S; Wang C; Zheng X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2012 May; 36(3):162-7. PubMed ID: 22916469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.